0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Overactive Bladder Treatment Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-9185
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Overactive Bladder Treatment Market Insights Forecast to 2025

Global Overactive Bladder Treatment Market Insights, Forecast to 2025

Code: QYRE-Auto-9185
Report
May 2019
116 Pages
QYResearch
Region: Global, North America, Europe, Japan, China, Central & South America, Africa, Middle East, Asia Pacific,
Description
Table of Content
Tables & Figures
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%. Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs. The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
The global Overactive Bladder Treatment market is valued at 4710 million US$ in 2018 and will reach 7230 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Overactive Bladder Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Overactive Bladder Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Overactive Bladder Treatment in these regions.
This research report categorizes the global Overactive Bladder Treatment market by top players/brands, region, type and end user. This report also studies the global Overactive Bladder Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Astellas Pharma
    Allergan
    Pfizer
    Teva (Activas)
    Johnson & Johnson

Market size by Product
    Anticholinergics
    Mirabegron
    Botox
Market size by End User
    Idiopathic Overactive Bladder
    Neurogenic Overactive Bladder

Market size by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Overactive Bladder Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Overactive Bladder Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of Overactive Bladder Treatment submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Overactive Bladder Treatment are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Overactive Bladder Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
    1.1 Overactive Bladder Treatment Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Overactive Bladder Treatment Market Size Growth Rate by Product
        1.4.2 Anticholinergics
        1.4.3 Mirabegron
        1.4.4 Botox
    1.5 Market by End User
        1.5.1 Global Overactive Bladder Treatment Market Size Growth Rate by End User
        1.5.2 Idiopathic Overactive Bladder
        1.5.3 Neurogenic Overactive Bladder
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Overactive Bladder Treatment Market Size
        2.1.1 Global Overactive Bladder Treatment Revenue 2014-2025
        2.1.2 Global Overactive Bladder Treatment Sales 2014-2025
    2.2 Overactive Bladder Treatment Growth Rate by Regions
        2.2.1 Global Overactive Bladder Treatment Sales by Regions
        2.2.2 Global Overactive Bladder Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Overactive Bladder Treatment Sales by Manufacturers
        3.1.1 Overactive Bladder Treatment Sales by Manufacturers
        3.1.2 Overactive Bladder Treatment Sales Market Share by Manufacturers
        3.1.3 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Overactive Bladder Treatment Revenue by Manufacturers
        3.2.1 Overactive Bladder Treatment Revenue by Manufacturers (2014-2019)
        3.2.2 Overactive Bladder Treatment Revenue Share by Manufacturers (2014-2019)
    3.3 Overactive Bladder Treatment Price by Manufacturers
    3.4 Overactive Bladder Treatment Manufacturing Base Distribution, Product Types
        3.4.1 Overactive Bladder Treatment Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Overactive Bladder Treatment Product Type
        3.4.3 Date of International Manufacturers Enter into Overactive Bladder Treatment Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Overactive Bladder Treatment Sales by Product
    4.2 Global Overactive Bladder Treatment Revenue by Product
    4.3 Overactive Bladder Treatment Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Overactive Bladder Treatment Breakdown Data by End User

6 North America
    6.1 North America Overactive Bladder Treatment by Countries
        6.1.1 North America Overactive Bladder Treatment Sales by Countries
        6.1.2 North America Overactive Bladder Treatment Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Overactive Bladder Treatment by Product
    6.3 North America Overactive Bladder Treatment by End User

7 Europe
    7.1 Europe Overactive Bladder Treatment by Countries
        7.1.1 Europe Overactive Bladder Treatment Sales by Countries
        7.1.2 Europe Overactive Bladder Treatment Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Overactive Bladder Treatment by Product
    7.3 Europe Overactive Bladder Treatment by End User

8 Asia Pacific
    8.1 Asia Pacific Overactive Bladder Treatment by Countries
        8.1.1 Asia Pacific Overactive Bladder Treatment Sales by Countries
        8.1.2 Asia Pacific Overactive Bladder Treatment Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Overactive Bladder Treatment by Product
    8.3 Asia Pacific Overactive Bladder Treatment by End User

9 Central & South America
    9.1 Central & South America Overactive Bladder Treatment by Countries
        9.1.1 Central & South America Overactive Bladder Treatment Sales by Countries
        9.1.2 Central & South America Overactive Bladder Treatment Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Overactive Bladder Treatment by Product
    9.3 Central & South America Overactive Bladder Treatment by End User

10 Middle East and Africa
    10.1 Middle East and Africa Overactive Bladder Treatment by Countries
        10.1.1 Middle East and Africa Overactive Bladder Treatment Sales by Countries
        10.1.2 Middle East and Africa Overactive Bladder Treatment Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Overactive Bladder Treatment by Product
    10.3 Middle East and Africa Overactive Bladder Treatment by End User

11 Company Profiles
    11.1 Astellas Pharma
        11.1.1 Astellas Pharma Company Details
        11.1.2 Company Business Overview
        11.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 Astellas Pharma Overactive Bladder Treatment Products Offered
        11.1.5 Astellas Pharma Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Company Business Overview
        11.2.3 Allergan Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Allergan Overactive Bladder Treatment Products Offered
        11.2.5 Allergan Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Company Business Overview
        11.3.3 Pfizer Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Pfizer Overactive Bladder Treatment Products Offered
        11.3.5 Pfizer Recent Development
    11.4 Teva (Activas)
        11.4.1 Teva (Activas) Company Details
        11.4.2 Company Business Overview
        11.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Teva (Activas) Overactive Bladder Treatment Products Offered
        11.4.5 Teva (Activas) Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Company Business Overview
        11.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Johnson & Johnson Overactive Bladder Treatment Products Offered
        11.5.5 Johnson & Johnson Recent Development

12 Future Forecast
    12.1 Overactive Bladder Treatment Market Forecast by Regions
        12.1.1 Global Overactive Bladder Treatment Sales Forecast by Regions 2019-2025
        12.1.2 Global Overactive Bladder Treatment Revenue Forecast by Regions 2019-2025
    12.2 Overactive Bladder Treatment Market Forecast by Product
        12.2.1 Global Overactive Bladder Treatment Sales Forecast by Product 2019-2025
        12.2.2 Global Overactive Bladder Treatment Revenue Forecast by Product 2019-2025
    12.3 Overactive Bladder Treatment Market Forecast by End User
    12.4 North America Overactive Bladder Treatment Forecast
    12.5 Europe Overactive Bladder Treatment Forecast
    12.6 Asia Pacific Overactive Bladder Treatment Forecast
    12.7 Central & South America Overactive Bladder Treatment Forecast
    12.8 Middle East and Africa Overactive Bladder Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Overactive Bladder Treatment Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables and Figures

    Figure Overactive Bladder Treatment Product Picture
    Table Overactive Bladder Treatment Market Segments
    Table Key Manufacturers Overactive Bladder Treatment Covered
    Table Global Overactive Bladder Treatment Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Overactive Bladder Treatment Sales Market Share by Product 2014-2025
    Figure Anticholinergics Product Picture
    Table Major Manufacturers of Anticholinergics
    Figure Mirabegron Product Picture
    Table Major Manufacturers of Mirabegron
    Figure Botox Product Picture
    Table Major Manufacturers of Botox
    Table Global Overactive Bladder Treatment Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Idiopathic Overactive Bladder
    Figure Neurogenic Overactive Bladder
    Figure Overactive Bladder Treatment Report Years Considered
    Figure Global Overactive Bladder Treatment Market Size 2014-2025 (Million US$)
    Figure Global Overactive Bladder Treatment Sales 2014-2025 (K Units)
    Table Global Overactive Bladder Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Overactive Bladder Treatment Sales by Regions 2014-2019 (K Units)
    Table Global Overactive Bladder Treatment Sales Market Share by Regions 2014-2019
    Figure Global Overactive Bladder Treatment Sales Market Share by Regions 2014-2019
    Figure 2018 Global Overactive Bladder Treatment Sales Market Share by Regions
    Table Global Overactive Bladder Treatment Revenue by Regions 2014-2019 (Million US$)
    Table Global Overactive Bladder Treatment Revenue Market Share by Regions 2014-2019
    Figure Global Overactive Bladder Treatment Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Overactive Bladder Treatment Revenue Market Share by Regions
    Table Global Overactive Bladder Treatment Sales by Manufacturers (2014-2019) (K Units)
    Table Global Overactive Bladder Treatment Sales Share by Manufacturers (2014-2019)
    Figure Global Overactive Bladder Treatment Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Overactive Bladder Treatment Revenue by Manufacturers (2014-2019) (Million USD)
    Table Overactive Bladder Treatment Revenue Share by Manufacturers (2014-2019)
    Figure Overactive Bladder Treatment Value Share by Manufacturers in 2018
    Table Key Manufacturers Overactive Bladder Treatment Price (2014-2019) (USD/Unit)
    Table Overactive Bladder Treatment Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Overactive Bladder Treatment Product Type
    Table Date of International Manufacturers Enter into Overactive Bladder Treatment Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table Global Overactive Bladder Treatment Sales Share by Product (2014-2019)
    Figure Global Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure Global Overactive Bladder Treatment Sales Market Share by Product in 2018
    Table Global Overactive Bladder Treatment Revenue by Product (2014-2019) (Million US$)
    Table Global Overactive Bladder Treatment Revenue Share by Product (2014-2019)
    Figure Global Overactive Bladder Treatment Revenue Market Share by Product (2014-2019)
    Figure Global Overactive Bladder Treatment Revenue Market Share by Product in 2018
    Table Overactive Bladder Treatment Price by Product 2014-2019 (USD/Unit)
    Table Global Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table Global Overactive Bladder Treatment Sales Share by End User (2014-2019)
    Figure Global Sales Overactive Bladder Treatment Market Share by End User (2014-2019)
    Figure Global Sales Overactive Bladder Treatment Market Share by End User in 2018
    Figure North America Overactive Bladder Treatment Sales Growth Rate 2014-2019 (K Units)
    Figure North America Overactive Bladder Treatment Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Overactive Bladder Treatment Sales by Countries (2014-2019) (K Units)
    Table North America Overactive Bladder Treatment Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Overactive Bladder Treatment Sales Market Share by Countries
    Table North America Overactive Bladder Treatment Revenue by Countries (2014-2019) (Million US$)
    Table North America Overactive Bladder Treatment Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Overactive Bladder Treatment Revenue Market Share by Countries
    Figure United States Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure United States Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table North America Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure 2018 North America Overactive Bladder Treatment Market Share by Product
    Table North America Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table North America Overactive Bladder Treatment Sales Market Share by End User (2014-2019)
    Figure 2018 North America Overactive Bladder Treatment Market Share by End User
    Figure Europe Overactive Bladder Treatment Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Overactive Bladder Treatment Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Overactive Bladder Treatment Sales by Countries (2014-2019) (K Units)
    Table Europe Overactive Bladder Treatment Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Overactive Bladder Treatment Sales Market Share by Countries
    Table Europe Overactive Bladder Treatment Revenue by Countries (2014-2019) (Million US$)
    Table Europe Overactive Bladder Treatment Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Overactive Bladder Treatment Revenue Market Share by Countries
    Figure Germany Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure France Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure UK Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table Europe Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Overactive Bladder Treatment Market Share by Product
    Table Europe Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table Europe Overactive Bladder Treatment Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Overactive Bladder Treatment Market Share by End User
    Figure Asia Pacific Overactive Bladder Treatment Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Overactive Bladder Treatment Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Overactive Bladder Treatment Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Overactive Bladder Treatment Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Overactive Bladder Treatment Sales Market Share by Countries
    Table Asia Pacific Overactive Bladder Treatment Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Overactive Bladder Treatment Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Overactive Bladder Treatment Revenue Market Share by Countries
    Figure China Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure China Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure India Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Overactive Bladder Treatment Market Share by Product
    Table Asia Pacific Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Overactive Bladder Treatment Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Overactive Bladder Treatment Market Share by End User
    Figure Central & South America Overactive Bladder Treatment Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Overactive Bladder Treatment Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Overactive Bladder Treatment Sales by Countries (2014-2019) (K Units)
    Table Central & South America Overactive Bladder Treatment Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Overactive Bladder Treatment Sales Market Share by Countries
    Table Central & South America Overactive Bladder Treatment Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Overactive Bladder Treatment Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Overactive Bladder Treatment Revenue Market Share by Countries
    Figure Brazil Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table Central & South America Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Overactive Bladder Treatment Market Share by Product
    Table Central & South America Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table Central & South America Overactive Bladder Treatment Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Overactive Bladder Treatment Market Share by End User
    Figure Middle East and Africa Overactive Bladder Treatment Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Overactive Bladder Treatment Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Overactive Bladder Treatment Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Overactive Bladder Treatment Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Overactive Bladder Treatment Sales Market Share by Countries
    Table Middle East and Africa Overactive Bladder Treatment Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries
    Figure GCC Countries Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Overactive Bladder Treatment Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Overactive Bladder Treatment Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Overactive Bladder Treatment Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Overactive Bladder Treatment Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Overactive Bladder Treatment Market Share by Product
    Table Middle East and Africa Overactive Bladder Treatment Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Overactive Bladder Treatment Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Overactive Bladder Treatment Market Share by End User
    Table Astellas Pharma Company Details
    Table Astellas Pharma Overactive Bladder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Astellas Pharma Recent Development
    Table Allergan Company Details
    Table Allergan Overactive Bladder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Allergan Recent Development
    Table Pfizer Company Details
    Table Pfizer Overactive Bladder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pfizer Recent Development
    Table Teva (Activas) Company Details
    Table Teva (Activas) Overactive Bladder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Teva (Activas) Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Overactive Bladder Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Johnson & Johnson Recent Development
    Table Global Overactive Bladder Treatment Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Overactive Bladder Treatment Sales Market Share Forecast by Regions 2019-2025
    Table Global Overactive Bladder Treatment Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Overactive Bladder Treatment Revenue Market Share Forecast by Regions 2019-2025
    Table Global Overactive Bladder Treatment Sales Forecast by Product 2019-2025 (K Units)
    Table Global Overactive Bladder Treatment Sales Market Share Forecast by Product 2019-2025
    Table Global Overactive Bladder Treatment Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Overactive Bladder Treatment Revenue Market Share Forecast by Product 2019-2025
    Table Global Overactive Bladder Treatment Sales Forecast by End User 2019-2025 (K Units)
    Table Global Overactive Bladder Treatment Sales Market Share Forecast by End User 2019-2025
    Figure North America Overactive Bladder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Overactive Bladder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Overactive Bladder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Overactive Bladder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Overactive Bladder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Overactive Bladder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Overactive Bladder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Overactive Bladder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Overactive Bladder Treatment Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Overactive Bladder Treatment Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Overactive Bladder Treatment Value Chain
    Table Overactive Bladder Treatment Customers List
    Table Overactive Bladder Treatment Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Treatment of Skin Fibrosis Market Size Status and Forecast 2021 2027
Global Treatment of Skin Fibrosis Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-36Q1139
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Extended Release Drug Market Size Status and Forecast 2021 2027
Global Extended Release Drug Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-23G2678
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Opioid Withdrawal Treatment Market Size Status and Forecast 2021 2027
Global Opioid Withdrawal Treatment Market Size, Status and Forecast 2021-2027

Hence this opioid dependence requires treatment which is known as opioids withdrawal treatment.Market Analysis and Insights Global Opioid Withdrawal Treatment MarketThe global Opioid Withdrawal Treatment market size is projected to reach US 2520 million by 2027 from US 1655.7 million in 2020 at a CAGR of 5.7 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Withdrawal Treatment market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-8H2983
Sun Jul 18 00:00:00 UTC 2021

Add to Cart